Dividends Inside 
BrightSpring Health Services, Inc.
BTSG
$62.92 (+ $0.50 + 0.80%)
Last updated: 2026-10-21 14:33 UTC
BrightSpring Health Services, Inc. trades under ticker BTSG on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US10950A1060, CUSIP 10950A106. Also searched as BrightSpring Health Services.
Related researchBTSG stock priceBTSG share price10950A106BrightSpring Health Services stockBrightSpring Health Services share price
About the Company
BrightSpring Health Services, Inc. is a U.S. home and community-based healthcare services platform focused on delivering integrated pharmacy and provider solutions for complex patient populations. The company operates through Pharmacy Solutions and Provider Services, offering services such as infusion and specialty pharmacy, home and community pharmacy, home health care, rehabilitation, and other clinical support services. Its care model serves patients across Medicare, Medicaid, and commercial insurance programs, with an emphasis on coordinated, person-centered care in home and community settings. BrightSpring Health Services plays an important role in the healthcare market by connecting pharmacy capabilities with direct care services, supporting patients who require ongoing, specialized, or chronic care management.
Price History
Latest News for BTSG
BrightSpring Health Services (BTSG) Is Up 10.3% After Raising 2026 Revenue Guidance And Q1 Beat – Has The Bull Case Changed?
In early May 2026, BrightSpring Health Services reported first-quarter results showing revenue of US$3.61 billion and net income of US$148.77 million, and also raised its full-year 2026 earnings guidance to expected revenues of US$14.73 billion to US$15.23 billion. The combination of outperformance in specialty pharmacy and infusion services, efficiency gains from automation, and successful home health integrations is reshaping how investors view BrightSpring’s earnings power and growth...
BrightSpring Beat And Guidance Raise Put Valuation And Debt In Focus
BrightSpring Health Services reported first quarter results that exceeded expectations, supported by specialty pharmacy and infusion therapies. Recent home health acquisitions were integrated and contributed to performance in the period. Management raised full year revenue and EBITDA guidance following the stronger quarter. BrightSpring Health Services (NasdaqGS: BTSG) has drawn attention with its latest update, as management tied the upbeat quarter to momentum in core healthcare service...
Zacks.com featured highlights include BrightSpring Health Services, StoneX and Vista
BrightSpring Health Services, StoneX and Vista have been highlighted in this Screen of The Week article.
Buy These 4 Stocks With Rising Cash Flows for Huge Gains
BTSG, SNEX, VIST and ORN stand out for improving cash flow trends, offering a resilience check beyond profits as uncertainty persists.
Buy These 4 Stocks With Robust Net Profit Margins to Boost Returns
Enhance your portfolio with BTSG, ARKO, SNEX and VIST, each exhibiting strong net profit margins and steady earnings growth.
BrightSpring Health Services’s Q1 Earnings Call: Our Top 5 Analyst Questions
BrightSpring Health Services delivered results in Q1 that surpassed Wall Street’s expectations, with the market responding positively to broad-based growth across both pharmacy and provider services. Management attributed performance to continued momentum in specialty pharmacy and infusion, as well as successful integration of recent acquisitions in home health. CEO Jon Rousseau noted, “We saw really good growth, particularly with the ramp-up of existing limited distribution drugs (LDDs), the la